
Healthcare / Pharma · NSE
Aakaar Medical Technologies Limited, established in June 2013, is a company focused on aesthetic medical solutions, offering a wide range of specialized cosmetic products and devices. It primarily caters to dermatologists, plastic surgeons, aesthetic physicians, and cosmetologists. The company provides both its own brands—comprising products made in India and devices produced internationally—as well as imported brands from countries like South Korea, Spain, Italy, and Austria. These products are mainly supplied to professionals who either use them during treatments or sell them to end users. Aakaar’s offerings include skincare for home and professional use, injectable and contouring products, hair care solutions such as growth serums and tablets, medifacial kits, and various medical devices. These devices are used for treatments like urinary incontinence, tattoo removal, skin rejuvenation, laser hair reduction, and hair transplants. With a presence across India, the company has a strong network of 90 trained sales and service engineers, supporting a large and satisfied customer base. It distributes its products in multiple states including Delhi, Haryana, Punjab, Chandigarh, Uttarakhand, Uttar Pradesh, Bihar, West Bengal, Assam, Gujarat, Madhya Pradesh, Maharashtra, Karnataka, Telangana, and Tamil Nadu.
Price Band
₹68 – ₹72
Issue Size
₹27.00 Cr
Lot Size
1600 shares
GMP
Est. Listing
₹72
at current GMP
Subscribed
2.25x
overall
Open
20 Jun 2025
Close
24 Jun 2025
Allotment
25 Jun 2025
Refund
26 Jun 2025
Demat Credit
27 Jun 2025
Listing
27 Jun 2025
Overall Subscription
2.25x
Total Demand
QIB Multiplier
3.51x
Institutions & Funds
NII / HNI
1.43x
High Net-Worth
Retail (RII)
1.93x
Individual Bidders
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | 712,000 | 2,496,000 | 3.51x |
| NIB | 604,400 | 863,600 | 1.43x |
| RETAIL | 1,248,000 | 2,411,200 | 1.93x |
| Total | 2,564,400 | 5,770,800 | 2.25x |
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| QIB | — | 7 | 0.00x |
| NIB | — | 123 | 0.00x |
| RETAIL | — | 1,507 | 0.00x |
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
Aakaar Medical Technologies Limited is bringing an initial public offering (IPO) in the Healthcare / Pharma sector with an aggregate issue size of ₹27 Crores. The shares are offered at a price band of ₹68 to ₹72 per equity share on NSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2025-06-24, the basis of allotment is scheduled to be finalized on 2025-06-25. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Bigshare Services Private Limited) or the BSE allotment checking window.
Currently, Aakaar Medical Technologies Limited IPO Grey Market Premium (GMP) is not actively quoted or is quoted flat at ₹0. The shares are expected to list close to the issue price band of ₹68 to ₹72 per equity share.
The retail lot size is 1600 shares requiring a minimum application amount of ₹1,15,200. Expected listing price is ₹72 per equity share.
The Aakaar Medical Technologies Limited IPO aggregate issue size is ₹27 Crores with an equity price band set at ₹68 to ₹72 per equity share. The retail lot size is 1600 shares requiring a minimum capital outlay of approx. ₹1,15,200.
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 2.25x (Retail: 1.93x, QIB: 3.51x, NII: 1.43x). You can track live multiples directly on our dedicated subscription page.
The basis of allotment will be published on the official registrar portal (Bigshare Services Private Limited) and the BSE status verification website on or around 2025-06-25. Investors can verify status using PAN card or application number.
Aakaar Medical Technologies Limited shares are scheduled to list on NSE on 2025-06-27.